The company said, "The Company generated increased adoption of its industry-leading laser with approximately 84% of U.S. Waterlase sales in the fourth quarter and full-year 2022 coming from new customers. The Company delivered an increased sales conversion rate throughout the year with the continued success of its Waterlase Exclusive Trial Program"
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on BIOL:
